-
1
-
-
53449086211
-
Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies
-
Lakatos PL, Lakatos L Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies. World J Gastroenterol 2008;14:3937-47.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 3937-3947
-
-
Lakatos, P.L.1
Lakatos, L.2
-
2
-
-
0141651527
-
Review article: The incidence and prevalence of colorectal cancer in inflammatory bowel disease
-
Munkholm P. Review article: The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003;18:1-5.
-
(2003)
Aliment Pharmacol Ther
, vol.18
, pp. 1-5
-
-
Munkholm, P.1
-
3
-
-
49649101872
-
Colorectal cancer and dysplasia in inflammatory bowel disease
-
Zisman TL, Rubin DT. Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol 2008;14:2662-9.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 2662-2669
-
-
Zisman, T.L.1
Rubin, D.T.2
-
4
-
-
33645994506
-
Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis
-
Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006;130:1030-8.
-
(2006)
Gastroenterology
, vol.130
, pp. 1030-1038
-
-
Rutter, M.D.1
Saunders, B.P.2
Wilkinson, K.H.3
Rumbles, S.4
Schofield, G.5
Kamm, M.A.6
-
5
-
-
0035080617
-
The risk of colorectal cancer in ulcerative colitis: A meta-analysis
-
Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001;48:526-35.
-
(2001)
Gut
, vol.48
, pp. 526-535
-
-
Eaden, J.A.1
Abrams, K.R.2
Mayberry, J.F.3
-
6
-
-
35348979243
-
Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: Current concepts
-
Levine JS, Burakoff R. Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: Current concepts. Inflamm Bowel Dis 2007;13:1293-8.
-
(2007)
Inflamm Bowel Dis
, vol.13
, pp. 1293-1298
-
-
Levine, J.S.1
Burakoff, R.2
-
7
-
-
35349016919
-
Chemoprevention of colorectal cancer
-
Das D, Arber N, Jankowski JA. Chemoprevention of colorectal cancer. Digestion 2007;76:51-67.
-
(2007)
Digestion
, vol.76
, pp. 51-67
-
-
Das, D.1
Arber, N.2
Jankowski, J.A.3
-
8
-
-
0035895263
-
Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis
-
Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001;134:89-95.
-
(2001)
Ann Intern Med
, vol.134
, pp. 89-95
-
-
Tung, B.Y.1
Emond, M.J.2
Haggitt, R.C.3
Bronner, M.P.4
Kimmey, M.B.5
Kowdley, K.V.6
-
9
-
-
0037382288
-
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
-
Pardi DS, Loftus EV Jr, Kremers WK, Keach J, Lindor KD. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003;124:889-93.
-
(2003)
Gastroenterology
, vol.124
, pp. 889-893
-
-
Pardi, D.S.1
Loftus Jr., E.V.2
Kremers, W.K.3
Keach, J.4
Lindor, K.D.5
-
10
-
-
21344446543
-
Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: A systematic review and metaanalysis of observational studies
-
Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: A systematic review and metaanalysis of observational studies. Am J Gastroenterol 2005;100:1345-53.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1345-1353
-
-
Velayos, F.S.1
Terdiman, J.P.2
Walsh, J.M.3
-
11
-
-
59149103298
-
Systematic review: Does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?
-
Andrews JM, Travis SP, Gibson PR, Gasche C. Systematic review: Does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes? Aliment Pharmacol Ther 2009 29 459-69
-
(2009)
Aliment Pharmacol Ther
, vol.29
, pp. 459-469
-
-
Andrews, J.M.1
Travis, S.P.2
Gibson, P.R.3
Gasche, C.4
-
12
-
-
0347994976
-
Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
-
Bernstein CN, Blanchard JF, Metge C, Yogendran M. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol 2003 98 2784-8
-
(2003)
Am J Gastroenterol
, vol.98
, pp. 2784-2788
-
-
Bernstein, C.N.1
Blanchard, J.F.2
Metge, C.3
Yogendran, M.4
-
13
-
-
0036742876
-
Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid
-
Bernstein CN, Eaden J, Steinhart AH, Munkholm P, Gordon PH. Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Inflamm Bowel Dis 2002;8:356-61.
-
(2002)
Inflamm Bowel Dis
, vol.8
, pp. 356-361
-
-
Bernstein, C.N.1
Eaden, J.2
Steinhart, A.H.3
Munkholm, P.4
Gordon, P.H.5
-
14
-
-
7444265772
-
Dialysis catheter-related bacteremia: Treatment and prophylaxis
-
Allon M. Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am J Kidney Dis 2004;44:779-91.
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 779-791
-
-
Allon, M.1
-
15
-
-
0031441397
-
Therapy of peritonitis today: Surgical management and adjuvant therapy strategies
-
Reith HB. [Therapy of peritonitis today: Surgical management and adjuvant therapy strategies]. Langenbecks Arch Chir 1997;382:S14-7.
-
(1997)
Langenbecks Arch Chir
, vol.382
-
-
Reith, H.B.1
-
16
-
-
7044235802
-
Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients
-
Koldehoff M, Zakrzewski JL. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents 2004;24:491-5.
-
(2004)
Int J Antimicrob Agents
, vol.24
, pp. 491-495
-
-
Koldehoff, M.1
Zakrzewski, J.L.2
-
17
-
-
0035884603
-
Taurolidine: Cytotoxic and mechanistic evaluation of a novel antineoplastic agent
-
Calabresi P, Goulette FA, Darnowski JW. Taurolidine: Cytotoxic and mechanistic evaluation of a novel antineoplastic agent. Cancer Res 2001;61:6816-21.
-
(2001)
Cancer Res
, vol.61
, pp. 6816-6821
-
-
Calabresi, P.1
Goulette, F.A.2
Darnowski, J.W.3
-
18
-
-
26244457004
-
Taurolidine: A new drug with anti-tumor and anti-angiogenic effects
-
Jacobi CA, Menenakos C, Braumann C. Taurolidine: A new drug with anti-tumor and anti-angiogenic effects. Anticancer Drugs 2005;16:917-21.
-
(2005)
Anticancer Drugs
, vol.16
, pp. 917-921
-
-
Jacobi, C.A.1
Menenakos, C.2
Braumann, C.3
-
19
-
-
37549046815
-
Synergistic effects in apoptosis induction by taurolidine and TRAIL in HCT-15 colon carcinoma cells
-
Chromik AM, Daigeler A, Hilgert C, Bulut D, Geisler A, Liu V, et al. Synergistic effects in apoptosis induction by taurolidine and TRAIL in HCT-15 colon carcinoma cells. J Invest Surg 2007;20:339-48.
-
(2007)
J Invest Surg
, vol.20
, pp. 339-348
-
-
Chromik, A.M.1
Daigeler, A.2
Hilgert, C.3
Bulut, D.4
Geisler, A.5
Liu, V.6
-
20
-
-
48149110373
-
Synergistic apoptotic effects of taurolidine and TRAIL on squamous carcinoma cells of the esophagus
-
Daigeler A, Chromik AM, Geisler A, Bulut D, Hilgert C, Krieg A, et al. Synergistic apoptotic effects of taurolidine and TRAIL on squamous carcinoma cells of the esophagus. Int J Oncol 2008;32:1205-20.
-
(2008)
Int J Oncol
, vol.32
, pp. 1205-1220
-
-
Daigeler, A.1
Chromik, A.M.2
Geisler, A.3
Bulut, D.4
Hilgert, C.5
Krieg, A.6
-
21
-
-
60549100517
-
TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma
-
Daigeler A, Brenzel C, Bulut D, Geisler A, Hilgert C, Lehnhardt M, et al. TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma. J Exp Clin Cancer Res 2008;27:82.
-
(2008)
J Exp Clin Cancer Res
, vol.27
, pp. 82
-
-
Daigeler, A.1
Brenzel, C.2
Bulut, D.3
Geisler, A.4
Hilgert, C.5
Lehnhardt, M.6
-
22
-
-
0036335928
-
The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism
-
Han Z, Ribbizi I, Pantazis P, Wyche J, Darnowski J, Calabresi P. The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanism. Anticancer Res 2002;22:1959-64.
-
(2002)
Anticancer Res
, vol.22
, pp. 1959-1964
-
-
Han, Z.1
Ribbizi, I.2
Pantazis, P.3
Wyche, J.4
Darnowski, J.5
Calabresi, P.6
-
23
-
-
4344566710
-
Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer
-
Darnowski JW, Goulette FA, Cousens LP, Chatterjee D, Calabresi P. Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer. Cancer Chemother Pharmacol 2004;54:249-58.
-
(2004)
Cancer Chemother Pharmacol
, vol.54
, pp. 249-258
-
-
Darnowski, J.W.1
Goulette, F.A.2
Cousens, L.P.3
Chatterjee, D.4
Calabresi, P.5
-
24
-
-
4544278144
-
The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis
-
Braumann C, Henke W, Jacobi CA, Dubiel W. The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis. Int J Cancer 2004;112:225-30.
-
(2004)
Int J Cancer
, vol.112
, pp. 225-230
-
-
Braumann, C.1
Henke, W.2
Jacobi, C.A.3
Dubiel, W.4
-
25
-
-
23144431723
-
Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine
-
Rodak R, Kubota H, Ishihara H, Eugster HP, Konu D, Mohler H, et al. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine. J Neurosurg 2005;102:1055-68.
-
(2005)
J Neurosurg
, vol.102
, pp. 1055-1068
-
-
Rodak, R.1
Kubota, H.2
Ishihara, H.3
Eugster, H.P.4
Konu, D.5
Mohler, H.6
-
26
-
-
61649096836
-
The antibacterial substance taurolidine exhibits anti-neoplastic action based on a mixed type of programmed cell death
-
Stendel R, Biefer HR, Dekany GM, Kubota H, Munz C, Wang S, et al. The antibacterial substance taurolidine exhibits anti-neoplastic action based on a mixed type of programmed cell death. Autophagy 2009;5:194-210.
-
(2009)
Autophagy
, vol.5
, pp. 194-210
-
-
Stendel, R.1
Biefer, H.R.2
Dekany, G.M.3
Kubota, H.4
Munz, C.5
Wang, S.6
-
27
-
-
33747603201
-
Prevention of disease progression in a patient with a gastric cancer-re-recurrence: Outcome after intravenous treatment with the novel antineoplastic agent taurolidine: Report of a case
-
Braumann C, Winkler G, Rogalla P, Menenakos C, Jacobi CA. Prevention of disease progression in a patient with a gastric cancer-re-recurrence: Outcome after intravenous treatment with the novel antineoplastic agent taurolidine: Report of a case. World J Surg Oncol 2006;4:34.
-
(2006)
World J Surg Oncol
, vol.4
, pp. 34
-
-
Braumann, C.1
Winkler, G.2
Rogalla, P.3
Menenakos, C.4
Jacobi, C.A.5
-
28
-
-
2442505874
-
Treatment of glioblastoma with intravenous taurolidine: First clinical experience
-
Stendel R, Picht T, Schilling A, Heidenreich J, Loddenkemper C, Janisch W, et al. Treatment of glioblastoma with intravenous taurolidine: First clinical experience. Anticancer Res 2004;24:1143-7.
-
(2004)
Anticancer Res
, vol.24
, pp. 1143-1147
-
-
Stendel, R.1
Picht, T.2
Schilling, A.3
Heidenreich, J.4
Loddenkemper, C.5
Janisch, W.6
-
29
-
-
34548379030
-
Dextran sulfate sodium-induced colitis-associated neoplasia: A promising model for the development of chemopreventive interventions
-
Clapper ML, Cooper HS, Chang WC. Dextran sulfate sodium-induced colitis-associated neoplasia: A promising model for the development of chemopreventive interventions. Acta Pharmacol Sin 2007;28:1450-9.
-
(2007)
Acta Pharmacol Sin
, vol.28
, pp. 1450-1459
-
-
Clapper, M.L.1
Cooper, H.S.2
Chang, W.C.3
-
30
-
-
0037370137
-
Pathology of mouse models of intestinal cancer: Consensus report and recommendations
-
Boivin GP, Washington K, Yang K, Ward JM, Pretlow TP, Russell R, et al. Pathology of mouse models of intestinal cancer: Consensus report and recommendations. Gastroenterology 2003;124:762-77.
-
(2003)
Gastroenterology
, vol.124
, pp. 762-777
-
-
Boivin, G.P.1
Washington, K.2
Yang, K.3
Ward, J.M.4
Pretlow, T.P.5
Russell, R.6
-
31
-
-
0344237231
-
A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate
-
Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003;94:965-73.
-
(2003)
Cancer Sci
, vol.94
, pp. 965-973
-
-
Tanaka, T.1
Kohno, H.2
Suzuki, R.3
Yamada, Y.4
Sugie, S.5
Mori, H.6
-
32
-
-
65449180675
-
Colorectal carcinogenesis: Review of human and experimental animal studies
-
Tanaka T. Colorectal carcinogenesis: Review of human and experimental animal studies. J Carcinog 2009;8:5.
-
(2009)
J Carcinog
, vol.8
, pp. 5
-
-
Tanaka, T.1
-
33
-
-
67649479395
-
Protein expression analysis of inflammation-related colon carcinogenesis
-
Yasui Y, Tanaka T. Protein expression analysis of inflammation-related colon carcinogenesis. J Carcinog 2009;8:10.
-
(2009)
J Carcinog
, vol.8
, pp. 10
-
-
Yasui, Y.1
Tanaka, T.2
-
34
-
-
0027224059
-
Clinicopathologic study of dextran sulfate sodium experimental murine colitis
-
Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-49.
-
(1993)
Lab Invest
, vol.69
, pp. 238-249
-
-
Cooper, H.S.1
Murthy, S.N.2
Shah, R.S.3
Sedergran, D.J.4
-
35
-
-
0027275654
-
Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin
-
Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 1993;38:1722-34.
-
(1993)
Dig Dis Sci
, vol.38
, pp. 1722-1734
-
-
Murthy, S.N.1
Cooper, H.S.2
Shim, H.3
Shah, R.S.4
Ibrahim, S.A.5
Sedergran, D.J.6
-
36
-
-
5044228671
-
Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate
-
Suzuki R, Kohno H, Sugie S, Tanaka T. Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate. Cancer Sci 2004;95:721-7.
-
(2004)
Cancer Sci
, vol.95
, pp. 721-727
-
-
Suzuki, R.1
Kohno, H.2
Sugie, S.3
Tanaka, T.4
-
37
-
-
16344394046
-
Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane
-
Suzuki R, Kohno H, Sugie S, Tanaka T. Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane. Histol Histopathol 2005;20:483-92.
-
(2005)
Histol Histopathol
, vol.20
, pp. 483-492
-
-
Suzuki, R.1
Kohno, H.2
Sugie, S.3
Tanaka, T.4
-
38
-
-
29744461120
-
Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice
-
Suzuki R, Kohno H, Sugie S, Nakagama H, Tanaka T. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis 2006;27:162-9.
-
(2006)
Carcinogenesis
, vol.27
, pp. 162-169
-
-
Suzuki, R.1
Kohno, H.2
Sugie, S.3
Nakagama, H.4
Tanaka, T.5
-
39
-
-
35748964730
-
Oral administration of taurolidine ameliorates chronic DSS colitis in mice
-
Chromik AM, Muller AM, Albrecht M, Rottmann S, Otte JM, Herdegen T, et al. Oral administration of taurolidine ameliorates chronic DSS colitis in mice. J Invest Surg 2007;20:273-82.
-
(2007)
J Invest Surg
, vol.20
, pp. 273-282
-
-
Chromik, A.M.1
Muller, A.M.2
Albrecht, M.3
Rottmann, S.4
Otte, J.M.5
Herdegen, T.6
-
40
-
-
34247847785
-
Genetic deletion of JNK1 and JNK2 aggravates the DSS-induced colitis in mice
-
Chromik AM, Muller AM, Korner J, Belyaev O, Holland-Letz T, Schmitz F, et al. Genetic deletion of JNK1 and JNK2 aggravates the DSS-induced colitis in mice. J Invest Surg 2007;20:23-33.
-
(2007)
J Invest Surg
, vol.20
, pp. 23-33
-
-
Chromik, A.M.1
Muller, A.M.2
Korner, J.3
Belyaev, O.4
Holland-Letz, T.5
Schmitz, F.6
-
41
-
-
0023340925
-
Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue
-
Remmele W, Stegner HE. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 1987;8:138-40.
-
(1987)
Pathologe
, vol.8
, pp. 138-140
-
-
Remmele, W.1
Stegner, H.E.2
-
43
-
-
0030770536
-
Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model
-
Jacobi CA, Ordemann J, Bohm B, Zieren HU, Sabat R, Muller JM. Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model. Am J Surg 1997;174:359-63.
-
(1997)
Am J Surg
, vol.174
, pp. 359-363
-
-
Jacobi, C.A.1
Ordemann, J.2
Bohm, B.3
Zieren, H.U.4
Sabat, R.5
Muller, J.M.6
-
45
-
-
18844366929
-
Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats
-
Nestler G, Schulz HU, Schubert D, Kruger S, Lippert H, Pross M. Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats. Surg Endosc 2005;19:280-4.
-
(2005)
Surg Endosc
, vol.19
, pp. 280-284
-
-
Nestler, G.1
Schulz, H.U.2
Schubert, D.3
Kruger, S.4
Lippert, H.5
Pross, M.6
-
46
-
-
0032751144
-
New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: Results of a tumor model in the rat
-
Jacobi CA, Peter FJ, Wenger FA, Ordemann J, Muller JM. New therapeutic strategies to avoid intra- and extraperitoneal metastases during laparoscopy: Results of a tumor model in the rat. Dig Surg 1999;16:393-9.
-
(1999)
Dig Surg
, vol.16
, pp. 393-399
-
-
Jacobi, C.A.1
Peter, F.J.2
Wenger, F.A.3
Ordemann, J.4
Muller, J.M.5
-
47
-
-
77950382454
-
Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines
-
Chromik AM, Daigeler A, Bulut D, Flier A, May C, Harati K, et al. Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines. J Exp Clin Cancer Res 2010;29:21.
-
(2010)
J Exp Clin Cancer Res
, vol.29
, pp. 21
-
-
Chromik, A.M.1
Daigeler, A.2
Bulut, D.3
Flier, A.4
May, C.5
Harati, K.6
-
48
-
-
34247337682
-
Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model
-
Opitz I, Van der Veen H, Witte N, Braumann C, Mueller JM, Jacobi CA. Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model. Eur Surg Res 2007;39:129-35.
-
(2007)
Eur Surg Res
, vol.39
, pp. 129-135
-
-
Opitz, I.1
Van Der Veen, H.2
Witte, N.3
Braumann, C.4
Mueller, J.M.5
Jacobi, C.A.6
-
49
-
-
0038353567
-
The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic- assisted bowel resection of colon carcinoma in a rat model
-
Opitz I, van der Veen HC, Braumann C, Ablassmaier B, Führer K, Jacobi CA. The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat model. Surg Endosc 2003;17:1098-104.
-
(2003)
Surg Endosc
, vol.17
, pp. 1098-1104
-
-
Opitz, I.1
Van Der Veen, H.C.2
Braumann, C.3
Ablassmaier, B.4
Führer, K.5
Jacobi, C.A.6
-
50
-
-
0032876925
-
Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model
-
Jacobi CA, Wildbrett P, Volk T, Muller JM. Influence of different gases and intraperitoneal instillation of antiadherent or cytotoxic agents on peritoneal tumor cell growth and implantation with laparoscopic surgery in a rat model. Surg Endosc 1999;13:1021-5.
-
(1999)
Surg Endosc
, vol.13
, pp. 1021-1025
-
-
Jacobi, C.A.1
Wildbrett, P.2
Volk, T.3
Muller, J.M.4
-
51
-
-
0030770536
-
Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model
-
Jacobi CA, Ordemann J, Böhm B, Zieren HU, Sabat R, Müller JM. Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model. Am J Surg 1997;174:359-63.
-
(1997)
Am J Surg
, vol.174
, pp. 359-363
-
-
Jacobi Ca, O.1
-
52
-
-
33845427624
-
Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy
-
Bobrich E, Braumann C, Opitz I, Menenakos C, Kristiansen G, Jacobi CA. Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy. J Surg Res 2007;137:75-82.
-
(2007)
J Surg Res
, vol.137
, pp. 75-82
-
-
Bobrich, E.1
Braumann, C.2
Opitz, I.3
Menenakos, C.4
Kristiansen, G.5
Jacobi, C.A.6
-
54
-
-
70449533679
-
Taurolidine in the prevention and therapy of lung metastases
-
Hoksch B, Rufer B, Gazdhar A, Bilici M, Beshay M, Gugger M, et al. Taurolidine in the prevention and therapy of lung metastases. Eur J Cardiothorac Surg 2009;36:1058-63.
-
(2009)
Eur J Cardiothorac Surg
, vol.36
, pp. 1058-1063
-
-
Hoksch, B.1
Rufer, B.2
Gazdhar, A.3
Bilici, M.4
Beshay, M.5
Gugger, M.6
-
55
-
-
23944517003
-
Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats
-
Braumann C, Schoenbeck M, Menenakos C, Kilian M, Jacobi CA. Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats. Clin Exp Metastasis 2005;22:77-83.
-
(2005)
Clin Exp Metastasis
, vol.22
, pp. 77-83
-
-
Braumann, C.1
Schoenbeck, M.2
Menenakos, C.3
Kilian, M.4
Jacobi, C.A.5
-
56
-
-
26244439461
-
High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats
-
Braumann C, Stuhldreier B, Bobrich E, Menenakos C, Rogalla S, Jacobi CA. High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats. J Surg Res 2005;129:129-35.
-
(2005)
J Surg Res
, vol.129
, pp. 129-135
-
-
Braumann, C.1
Stuhldreier, B.2
Bobrich, E.3
Menenakos, C.4
Rogalla, S.5
Jacobi, C.A.6
-
57
-
-
0043238941
-
Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy
-
Braumann C, Ordemann J, Kilian M, Wenger FA, Jacobi CA. Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy. Clin Exp Metastasis 2003;20:387-94.
-
(2003)
Clin Exp Metastasis
, vol.20
, pp. 387-394
-
-
Braumann, C.1
Ordemann, J.2
Kilian, M.3
Wenger, F.A.4
Jacobi, C.A.5
-
58
-
-
0034788410
-
Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats
-
Braumann C, Ordemann J, Wildbrett P, Jacobi CA. Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats. Clin Exp Metastasis 2000;18:547-52.
-
(2000)
Clin Exp Metastasis
, vol.18
, pp. 547-552
-
-
Braumann, C.1
Ordemann, J.2
Wildbrett, P.3
Jacobi, C.A.4
-
59
-
-
64949162680
-
Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: A multicentre prospective randomized trial
-
Braumann C, Gutt CN, Scheele J, Menenakos C, Willems W, Mueller JM, et al. Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: A multicentre prospective randomized trial. World J Surg Oncol 2009;7:32.
-
(2009)
World J Surg Oncol
, vol.7
, pp. 32
-
-
Braumann, C.1
Gutt, C.N.2
Scheele, J.3
Menenakos, C.4
Willems, W.5
Mueller, J.M.6
-
60
-
-
0027458020
-
The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes
-
Dofferhoff AS, Esselink MT, de Vries-Hospers HG, van Zanten A, Bom VJ, Weits J, et al. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes. J Antimicrob Chemother 1993;31:373-84.
-
(1993)
J Antimicrob Chemother
, vol.31
, pp. 373-384
-
-
Dofferhoff, A.S.1
Esselink, M.T.2
De Vries-Hospers, H.G.3
Van Zanten, A.4
Bom, V.J.5
Weits, J.6
-
61
-
-
0026246461
-
Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells
-
Bedrosian I, Sofia RD, Wolff SM, Dinarello CA. Taurolidine, an analogue of the amino acid taurine, suppresses interleukin 1 and tumor necrosis factor synthesis in human peripheral blood mononuclear cells. Cytokine 1991;3:568-75.
-
(1991)
Cytokine
, vol.3
, pp. 568-575
-
-
Bedrosian, I.1
Sofia, R.D.2
Wolff, S.M.3
Dinarello, C.A.4
-
62
-
-
0032706849
-
Local treatment of generalised peritonitis in rats; Effects on bacteria, endotoxin and mortality
-
Rosman C, Westerveld GJ, Kooi K, Bleichrodt RP. Local treatment of generalised peritonitis in rats; effects on bacteria, endotoxin and mortality. Eur J Surg 1999;165:1072-9.
-
(1999)
Eur J Surg
, vol.165
, pp. 1072-1079
-
-
Rosman, C.1
Westerveld, G.J.2
Kooi, K.3
Bleichrodt, R.P.4
-
63
-
-
0029792352
-
Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats
-
Rosman C, Westerveld GJ, van Oeveren W, Kooi K, Bleichrodt RP. Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats. Eur Surg Res 1996;28:351-60.
-
(1996)
Eur Surg Res
, vol.28
, pp. 351-360
-
-
Rosman, C.1
Westerveld, G.J.2
Van Oeveren, W.3
Kooi, K.4
Bleichrodt, R.P.5
-
64
-
-
0029133319
-
Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine
-
Watson RW, Redmond HP, Mc Carthy J, Bouchier-Hayes D. Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine. J Leukoc Biol 1995;58:299-306.
-
(1995)
J Leukoc Biol
, vol.58
, pp. 299-306
-
-
Watson, R.W.1
Redmond, H.P.2
Mc Carthy, J.3
Bouchier-Hayes, D.4
-
65
-
-
49749108849
-
Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients
-
Simon A, Ammann RA, Wiszniewsky G, Bode U, Fleischhack G, Besuden MM. Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. BMC Infect Dis 2008;8:102.
-
(2008)
BMC Infect Dis
, vol.8
, pp. 102
-
-
Simon, A.1
Ammann, R.A.2
Wiszniewsky, G.3
Bode, U.4
Fleischhack, G.5
Besuden, M.M.6
-
66
-
-
0019732864
-
Therapy of purulent peritonitis: Documentation of 78 cases and experience with taurolin (author′s transl)
-
Linder MM, Ott W, Wesch G, Wicki O, Marti MC, Moser G. [Therapy of purulent peritonitis: Documentation of 78 cases and experience with taurolin (author′s transl)]. Langenbecks Arch Chir 1981;353:241-50.
-
(1981)
Langenbecks Arch Chir
, vol.353
, pp. 241-250
-
-
Linder, M.M.1
Ott, W.2
Wesch, G.3
Wicki, O.4
Marti, M.C.5
Moser, G.6
-
67
-
-
0019504615
-
The treatment of peritonitis by an antiseptic - Taurolin
-
Browne MK. The treatment of peritonitis by an antiseptic - taurolin. Pharmatherapeutica 1981;2:517-22.
-
(1981)
Pharmatherapeutica
, vol.2
, pp. 517-522
-
-
Browne, M.K.1
-
68
-
-
0020645212
-
Drug therapy of peritonitis: 6-year experience with the chemotherapeutic agent and anti-endotoxin taurolin
-
Wesch G, Petermann C, Linder MM. [Drug therapy of peritonitis: 6-year experience with the chemotherapeutic agent and anti-endotoxin taurolin]. Fortschr Med 1983;101:545-50.
-
(1983)
Fortschr Med
, vol.101
, pp. 545-550
-
-
Wesch, G.1
Petermann, C.2
Linder, M.M.3
-
69
-
-
0028567296
-
Enteral and parenteral anti-endotoxin treatment in experimental colitis
-
Gardiner KR, Anderson NH, McCaigue MD, Erwin PJ, Halliday MI, Rowlands BJ. Enteral and parenteral anti-endotoxin treatment in experimental colitis. Hepatogastroenterology 1994;41:554-8.
-
(1994)
Hepatogastroenterology
, vol.41
, pp. 554-558
-
-
Gardiner, K.R.1
Anderson, N.H.2
McCaigue, M.D.3
Erwin, P.J.4
Halliday, M.I.5
Rowlands, B.J.6
-
70
-
-
0036953625
-
Wnt/beta-catenin/tcf signaling: A critical pathway in gastrointestinal tumorigenesis
-
Kolligs FT, Bommer G, Göke B. Wnt/beta-catenin/tcf signaling: A critical pathway in gastrointestinal tumorigenesis. Digestion 2002;66:131-44.
-
(2002)
Digestion
, vol.66
, pp. 131-144
-
-
Kolligs Ft, B.1
-
72
-
-
0034052970
-
Dysplasia and cancer in the dextran sulfate sodium mouse colitis model: Relevance to colitis-associated neoplasia in the human: A study of histopathology, B-catenin and p53 expression and the role of inflammation
-
Cooper HS, Murthy S, Kido K, Yoshitake H, Flanigan A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model: Relevance to colitis-associated neoplasia in the human: A study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis 2000;21:757-68.
-
(2000)
Carcinogenesis
, vol.21
, pp. 757-768
-
-
Cooper, H.S.1
Murthy, S.2
Kido, K.3
Yoshitake, H.4
Flanigan, A.5
-
73
-
-
0344237231
-
A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate
-
Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003;94:965-73.
-
(2003)
Cancer Sci
, vol.94
, pp. 965-973
-
-
Tanaka, T.1
Kohno, H.2
Suzuki, R.3
Yamada, Y.4
Sugie, S.5
Mori, H.6
-
74
-
-
2342430807
-
Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium
-
Fujii S, Fujimori T, Kawamata H, Takeda J, Kitajima K, Omotehara F, et al. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium. Gut 2004;53:710-6.
-
(2004)
Gut
, vol.53
, pp. 710-716
-
-
Fujii, S.1
Fujimori, T.2
Kawamata, H.3
Takeda, J.4
Kitajima, K.5
Omotehara, F.6
-
75
-
-
25144490062
-
Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands
-
Kohno H, Suzuki R, Sugie S, Tanaka T. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer 2005;5:46.
-
(2005)
BMC Cancer
, vol.5
, pp. 46
-
-
Kohno, H.1
Suzuki, R.2
Sugie, S.3
Tanaka, T.4
-
76
-
-
0033913603
-
Control of beta-catenin signaling in tumor development
-
discussion 33-5
-
Behrens J. Control of beta-catenin signaling in tumor development. Ann N Y Acad Sci 2000;910:21-33; discussion 33-5.
-
(2000)
Ann N y Acad Sci
, vol.910
, pp. 21-33
-
-
Behrens, J.1
-
77
-
-
67649352637
-
Nuclear cyclin D1: An oncogenic driver in human cancer
-
Kim JK, Diehl JA. Nuclear cyclin D1: An oncogenic driver in human cancer. J Cell Physiol 2009;220:292-6.
-
(2009)
J Cell Physiol
, vol.220
, pp. 292-296
-
-
Kim, J.K.1
Diehl, J.A.2
-
78
-
-
34147096292
-
Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression
-
Tashiro E, Tsuchiya A, Imoto M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci 2007;98:629-35.
-
(2007)
Cancer Sci
, vol.98
, pp. 629-635
-
-
Tashiro, E.1
Tsuchiya, A.2
Imoto, M.3
-
79
-
-
46349089819
-
Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis-associated carcinogenesis
-
Assi K, Mills J, Owen D, Ong C, St Arnaud R, Dedhar S, et al. Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis-associated carcinogenesis. Gut 2008;57:931-40.
-
(2008)
Gut
, vol.57
, pp. 931-940
-
-
Assi, K.1
Mills, J.2
Owen, D.3
Ong, C.4
St Arnaud, R.5
Dedhar, S.6
-
80
-
-
3142669010
-
SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes
-
Blache P, van de Wetering M, Duluc I, Domon C, Berta P, Freund JN, et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol 2004;166:37-47.
-
(2004)
J Cell Biol
, vol.166
, pp. 37-47
-
-
Blache, P.1
Van De Wetering, M.2
Duluc, I.3
Domon, C.4
Berta, P.5
Freund, J.N.6
-
81
-
-
21344447478
-
The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner
-
Yano F, Kugimiya F, Ohba S, Ikeda T, Chikuda H, Ogasawara T, et al. The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner. Biochem Biophys Res Commun 2005;333:1300-8.
-
(2005)
Biochem Biophys Res Commun
, vol.333
, pp. 1300-1308
-
-
Yano, F.1
Kugimiya, F.2
Ohba, S.3
Ikeda, T.4
Chikuda, H.5
Ogasawara, T.6
-
82
-
-
2442514340
-
Interactions between Sox9 and beta-catenin control chondrocyte differentiation
-
Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 2004;18:1072-87.
-
(2004)
Genes Dev
, vol.18
, pp. 1072-1087
-
-
Akiyama, H.1
Lyons, J.P.2
Mori-Akiyama, Y.3
Yang, X.4
Zhang, R.5
Zhang, Z.6
-
83
-
-
0033813919
-
Transcriptional mechanisms of chondrocyte differentiation
-
de Crombrugghe B, Lefebvre V, Behringer RR, Bi W, Murakami S, Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol 2000;19:389-94.
-
(2000)
Matrix Biol
, vol.19
, pp. 389-394
-
-
De Crombrugghe, B.1
Lefebvre, V.2
Behringer, R.R.3
Bi, W.4
Murakami, S.5
Huang, W.6
-
84
-
-
34547525676
-
Sox9 coordinates a transcriptional network in pancreatic progenitor cells
-
Lynn FC, Smith SB, Wilson ME, Yang KY, Nekrep N, German MS. Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl Acad Sci U S A 2007;104:10500-5.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 10500-10505
-
-
Lynn, F.C.1
Smith, S.B.2
Wilson, M.E.3
Yang, K.Y.4
Nekrep, N.5
German, M.S.6
-
86
-
-
32244445399
-
Sox9 in testis determination
-
Kobayashi A, Chang H, Chaboissier MC, Schedl A, Behringer RR. Sox9 in testis determination. Ann N Y Acad Sci 2005;1061:9-17.
-
(2005)
Ann N y Acad Sci
, vol.1061
, pp. 9-17
-
-
Kobayashi, A.1
Chang, H.2
Chaboissier, M.C.3
Schedl, A.4
Behringer, R.R.5
-
87
-
-
35348813142
-
SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation
-
Passeron T, Valencia JC, Bertolotto C, Hoashi T, Le Pape E, Takahashi K, et al. SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation. Proc Natl Acad Sci U S A 2007;104:13984-9.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 13984-13989
-
-
Passeron, T.1
Valencia, J.C.2
Bertolotto, C.3
Hoashi, T.4
Le Pape, E.5
Takahashi, K.6
-
88
-
-
34547956892
-
Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium
-
Bastide P, Darido C, Pannequin J, Kist R, Robine S, Marty-Double C, et al. Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. J Cell Biol 2007;178:635-48.
-
(2007)
J Cell Biol
, vol.178
, pp. 635-648
-
-
Bastide, P.1
Darido, C.2
Pannequin, J.3
Kist, R.4
Robine, S.5
Marty-Double, C.6
-
89
-
-
56149095458
-
Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis
-
de Bont JM, Kros JM, Passier MM, Reddingius RE, Sillevis Smitt PA, Luider TM, et al. Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro Oncol 2008;10:648-60.
-
(2008)
Neuro Oncol
, vol.10
, pp. 648-660
-
-
De Bont, J.M.1
Kros, J.M.2
Passier, M.M.3
Reddingius, R.E.4
Sillevis Smitt, P.A.5
Luider, T.M.6
-
90
-
-
50549104322
-
Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells
-
Endo Y, Deonauth K, Prahalad P, Hoxter B, Zhu Y, Byers SW. Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells. PLoS One 2008;3:e2714.
-
(2008)
PLoS One
, vol.3
-
-
Endo, Y.1
Deonauth, K.2
Prahalad, P.3
Hoxter, B.4
Zhu, Y.5
Byers, S.W.6
-
91
-
-
40949145618
-
SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion
-
Wang H, Leav I, Ibaragi S, Wegner M, Hu GF, Lu ML, et al. SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res 2008;68:1625-30.
-
(2008)
Cancer Res
, vol.68
, pp. 1625-1630
-
-
Wang, H.1
Leav, I.2
Ibaragi, S.3
Wegner, M.4
Hu, G.F.5
Lu, M.L.6
-
92
-
-
33645026054
-
A transcriptome anatomy of human colorectal cancers
-
Lü B, Xu J, Lai M, Zhang H, Chen J. A transcriptome anatomy of human colorectal cancers. BMC Cancer 2006;6:40.
-
(2006)
BMC Cancer
, vol.6
, pp. 40
-
-
Lü, B.X.1
-
93
-
-
58049208376
-
Analysis of SOX9 expression in colorectal cancer
-
Lü B, Fang Y, Xu J, Wang L, Xu F, Xu E, et al. Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol 2008;130:897-904.
-
(2008)
Am J Clin Pathol
, vol.130
, pp. 897-904
-
-
Lü, B.F.1
|